Table 2.
Indications for solid tumors.
| Cancer | N° Indications (%) |
|---|---|
| Lung | 34 (26) |
| NSCLC | 32 |
| SCLC | 2 |
| Breast | 21 (16) |
| Genitourinary | 21 (16) |
| Renal cell | 8 |
| Prostate | 7 |
| Urothelial | 6 |
| Skin | 16 (12) |
| Melanoma | 13 |
| Squamous/basocellular | 2 |
| Merkel | 1 |
| Gastro-intestinal | 15 (11.2) |
| Colorectal | 5 |
| Hepatocellular | 5 |
| Pancreatic | 2 |
| Gastric | 1 |
| GIST | 1 |
| Esophageal | 1 |
| Gynecological | 11 (8.3) |
| Ovarian | 10 |
| Cervix | 1 |
| Head and neck | 4 (3) |
| Thyroid | 4 (3) |
| Soft tissue sarcoma | 2 (1.5) |
| Neuroendocrine | 2 (1.5) |
| NTRK positive | 2 (1.5) |
| Total | 132 (100) |
NSCLC: non-small cell lung cancer; SCLC: small cell lung cancer.